Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing

Martin Law, Dominique Laurent Couturier, Babak Choodari-Oskooei, Phillip Crout, Carrol Gamble, Peter Jacko, Philip Pallmann, Mark Pilling, David S S. Robertson, Michael Robling, Matthew R R. Sydes, Sofía S S. Villar, James Wason, Graham Wheeler, S.  Faye Williamson, Christina Yap, Thomas Jaki

Research output: Contribution to journalComment/debatepeer-review

3 Citations (Scopus)
Original languageEnglish
Article number640
JournalTrials
Volume24
Issue number1
DOIs
Publication statusPublished - Dec 2023
Externally publishedYes

ASJC Scopus Subject Areas

  • Medicine (miscellaneous)
  • Pharmacology (medical)

Keywords

  • Consultation
  • Data sharing
  • Legislation

Fingerprint

Dive into the research topics of 'Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing'. Together they form a unique fingerprint.

Cite this

Law, M., Couturier, D. L., Choodari-Oskooei, B., Crout, P., Gamble, C., Jacko, P., Pallmann, P., Pilling, M., Robertson, DS. S., Robling, M., Sydes, MR. R., Villar, SS. S., Wason, J., Wheeler, G., Williamson, S. F., Yap, C., & Jaki, T. (2023). Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing. Trials, 24(1), Article 640. https://doi.org/10.1186/s13063-023-07576-7